Hide Board Information

Show Board Information

Powershares Fundamental Pure Mid Growth PXMG

Board Mod: Add me as mod

Asst Mods:

Last Post: 10/29/2012 7:30:55 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

1. PXMG Company Profile

    

2. PXMG Time & Sales

    

3. PXMG Recent News

    

4. PXMG Filings

    

5. PXMG Financials

    

6. PXMG Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Powershares Fundamental Pure Mid Growth PXMG

Recent Articles

• Guardian Capital's October 2025 ETF Cash Distributions Explained
• Celebrating a Legacy: Tom Mitchell's Impact on Fabrinet's Growth
• Exciting Developments at Climb Bio for 2025 Kidney Week
• Foresight VCT PLC's Strategic Share Buyback Announcement
• XORTX Pursues Innovative Kidney Fibrosis Therapies with New Deal
• Sanofi Aims for Rezurock Approval in Chronic GVHD Treatment
• Exxon Mobil Strengthens Indian Market with Oil Supply
• EU Committee Backs Sanofi’s Wayrilz for Immune Thrombocytopenia
• Analysts See $8 Trillion Opportunity Through AI Growth
• Three Energy Stocks to Consider for Investment Growth
• Comerica's Thriving Growth Shown in Recent Financial Results
• Laminated Glass Market Expected to Reach $54.50 Billion Soon
• Bank of America to Redeem €1.75 Billion in Senior Notes Soon
• Boston Scientific Broadens Chronic Pain Solutions with Nalu Deal
• Illuminating Artistry: Manar Abu Dhabi's Creative Showcase
• Empowering ASEAN's Zero-Carbon Future with Smart Technologies
• Natural Grocers Hosts Family Halloween Festivities This Fall
• Celebrating Seven Years of Legalization: Tilray's Success Story
• Fabrinet Transitions Leadership as Founder Tom Mitchell Retires
• Sight Sciences Secures Medicare Pricing for TearCare System
• XORTX's Strategic Acquisition of VB4-P5 to Combat Kidney Disease
• Tonix Pharmaceuticals Showcases TNX-801 Vaccine Data
• Major Drilling Launches Normal Course Issuer Bid Program
• Eledon Pharmaceuticals' Promising Results from BESTOW Trial Unveiled
• Climb Bio Showcases Promising Developments in Nephrology Research
• Leadership at Chicago Atlantic Invests in Company Growth
• Sanofi's Wayrilz Receives Positive CHMP Recommendation for ITP Treatment
• Foresight Ventures VCT PLC Announces Equity Allocation Details
• Resilience Enhances Tech E&O Insurance for Large Clients
• Saudi Arabia Pursues Strategic Defense Agreement with US
• Doral Renewables' CEO Nick Cohen Receives Prestigious Honor
• Comerica's Strong Performance in Q3 2025 Financial Results
• A&W Food Services Reports Q3 2025 Financial Performance Insights
• Approval of BRINSUPRI™: A Transformation in NCFB Treatment
• Huntington Bancshares Reports Impressive Q3 Earnings Growth
• Western Midstream's Upcoming Conference Call for Earnings
• Huntington Bancshares Achieves Remarkable Growth in Q3 2025
• Discovering Miracles: A Heartwarming Baseball Tale
• Essential Tips for Selecting Quality Home Service Professionals
• Gibson Garage Miami: A New Musical Hub Set to Open Soon
• Emerita Resources Expands El Cura Deposit with High-Grade Drilling
• Jackbit Recognized as Top No KYC Crypto Casino for Players
• Exciting Developments at Mutuum Finance as Funding Approaches $20M
• Sanofi's Rezurock Faces Regulatory Setback for cGVHD Treatment
• Empowering Homebuyers: TransUnion's Innovative Mortgage Solutions
• Upcoming Conference Call for Genco Shipping's Q3 Results
• US-China Trade Tensions Impact Tech Stocks and Trade Dynamics
• Jackbit Emerges as the Top Crypto Casino with No KYC Policy
• Explore Creative Art Journeys at Hawaii Fluid Art Pasadena
• Highlights from the Latest Canadian Press Announcements